ArticleNature cancer2023

Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.

Isao Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.